AIM ImmunoTech (AIM) Asset Utilization Ratio (2018 - 2024)
Historic Asset Utilization Ratio for ImmunoTech (AIM) over the last 9 years, with Q3 2024 value amounting to 0.0.
- ImmunoTech's Asset Utilization Ratio rose 6630.57% to 0.0 in Q3 2024 from the same period last year, while for Sep 2024 it was 0.0, marking a year-over-year increase of 6630.57%. This contributed to the annual value of 0.01 for FY2024, which is N/A changed from last year.
- Latest data reveals that ImmunoTech reported Asset Utilization Ratio of 0.0 as of Q3 2024, which was up 6630.57% from 0.01 recorded in Q2 2024.
- In the past 5 years, ImmunoTech's Asset Utilization Ratio ranged from a high of 0.01 in Q2 2024 and a low of 0.0 during Q1 2020
- Its 3-year average for Asset Utilization Ratio is 0.0, with a median of 0.0 in 2023.
- Its Asset Utilization Ratio has fluctuated over the past 5 years, first tumbled by 8980.0% in 2020, then surged by 6630.57% in 2024.
- Over the past 3 years, ImmunoTech's Asset Utilization Ratio (Quarter) stood at 0.0 in 2020, then skyrocketed by 121.92% to 0.0 in 2023, then decreased by 5.59% to 0.0 in 2024.
- Its last three reported values are 0.0 in Q3 2024, 0.01 for Q2 2024, and 0.01 during Q1 2024.